Spero Therapeutics, Inc. (SPRO) Net Income by Year
Spero Therapeutics, Inc. reported $8.6M in net income in fiscal year 2025. This represents an increase of 112.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $7.4M in net income. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Spero Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SPRO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
SPRO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Spero Therapeutics, Inc. financials
Frequently Asked Questions
What was Spero Therapeutics, Inc.'s net income in fiscal year 2025?
Spero Therapeutics, Inc. reported $8.6M in net income in fiscal year 2025.
How fast is Spero Therapeutics, Inc.'s net income growing?
Spero Therapeutics, Inc. (SPRO) net income rose by 112.5% year over year, from -$68.6M to $8.6M in fiscal year 2025.
What is Spero Therapeutics, Inc.'s net income over the last twelve months?
Spero Therapeutics, Inc. (SPRO) reported $7.4M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Spero Therapeutics, Inc.'s net income changed over the years?
Across the 11 fiscal years this page covers, Spero Therapeutics, Inc. (SPRO) net income went from -$10.2M in fiscal year 2015 to $8.6M in fiscal year 2025.
What was Spero Therapeutics, Inc.'s net income in the most recent quarter?
Spero Therapeutics, Inc. (SPRO) reported -$9.6M in net income in Q2 2026. This represents a decrease of 461.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Spero Therapeutics, Inc. (SPRO) reported on that line in every period on record.